| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |